LEADER 04575nam 2200589Ia 450 001 9910779507103321 005 20200520144314.0 010 $a1-61942-869-5 035 $a(CKB)2550000001040691 035 $a(EBL)3017873 035 $a(SSID)ssj0000918868 035 $a(PQKBManifestationID)12343231 035 $a(PQKBTitleCode)TC0000918868 035 $a(PQKBWorkID)10908813 035 $a(PQKB)11540774 035 $a(MiAaPQ)EBC3017873 035 $a(Au-PeEL)EBL3017873 035 $a(CaPaEBR)ebr10654844 035 $a(OCoLC)923654006 035 $a(EXLCZ)992550000001040691 100 $a20111102d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAtaxia$b[electronic resource] $ecauses, symptoms and treatment /$fSung Hoi Hong, editor 210 $aNew York $cNova Science Publishers$dc2012 215 $a1 online resource (213 p.) 225 0 $aNeuroscience research progress 300 $aDescription based upon print version of record. 311 $a1-61942-867-9 320 $aIncludes bibliographical references and index. 327 $a""ATAXIA ""; ""ATAXIA ""; ""CONTENTS ""; ""PREFACE ""; ""ROLE OF THE ATAXIA TELANGIECTASIA MUTATED PROTEIN IN STRESS-INDUCED PREMATURE SENESCENCE ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""ATM ACTIVATION ""; ""ATM SUBSTRATES ""; ""P53 STRUCTURE, ACTIVATION AND FUNCTION ""; ""ROLES OF ATM AND P53 IN DNA REPAIR""; ""MULTIPLE FUNCTIONS OF P21 IN THE ATM NETWORK ""; ""SEQUENTIAL WAVES OF P53 ACTIVATION BY DNA DAMAGE ""; ""ATM-DEPENDENT SENESCENCE ""; ""ATM-INDEPENDENT SENESCENCE ""; ""ROLE OF ATM IN PREVENTING ESCAPE FROM SIPS: A NOVEL TUMOR SUPPRESSOR FUNCTION BEYOND P53? "" 327 $a""POTENTIAL THERAPEUTIC APPROACHES FOR THE TREATMENT OF AT """"CONCLUSION""; ""ACKNOWLEDGMENTS ""; ""REFERENCES""; ""ATAXIA TELANGIECTASIA: MOLECULAR BASIS, DIAGNOSIS AND TREATMENT ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""CLINICAL FEATURES OF A-T ""; ""Neurological Phenotype and Cutaneous Manifestations ""; ""Immunodeficiency and Pulmonary Complications ""; ""Predisposition to Cancer and Chromosomal Instability""; ""Endocrine Dysfunction ""; ""PATHOGENESIS AND MOLECULAR DEFECT ""; ""ATM and Neurodegeneration""; ""ATM and Oxidative Stress ""; ""DIAGNOSIS AND TREATMENT ""; ""CONCLUSION "" 327 $a""REFERENCES """"THE NEUROBIOLOGY OF EPISODIC ATAXIA TYPE 1, A SHAKER-LIKE K+ CHANNEL DISORDER ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""STRUCTURE AND FUNCTION OF SHAKER-LIKE K+ CHANNELS ""; ""PHYSIOLOGICAL ROLE OF KV CHANNELS ""; ""Hippocampus ""; ""Cerebellum ""; ""Sciatic Nerve ""; ""BIOTECHNOLOGY FOR STUDYING ION CHANNELS ""; ""EPISODIC ATAXIA TYPE 1: ""; ""Clinical Findings ""; ""Genetic Causes ""; ""Molecular Pathogenetic Mechanisms Underlying EA1""; ""Animal Models of EA1""; ""Treatment of EA1 ""; ""BRIEF OVERVIEW OF RELATED ATAXIA DISORDERS ""; ""CONCLUSION ""; ""ACKNOWLEDGMENTS "" 327 $a""REFERENCES """"MITOCHONDRIAL ATAXIAS ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""ATAXIA IN MITOCHONDRIAL DISORDERS ""; ""MtDNA Point Mutations ""; ""MtDNA Sporadic Rearrangements ""; ""Infantile Onset Spinocerebellar Ataxia ""; ""POLG1-Related Diseases ""; ""OPA1-Related Diseases ""; ""Coenzyme Q10 Deficiency ""; ""FRIEDREICH ATAXIA ""; ""Mitochondrial Therapies for Friedreich Ataxia ""; ""MITOCHONDRIA AND OTHER GENETIC ATAXIAS ""; ""Dominant Spino-Cerebellar Ataxias ""; ""X-Linked Ataxias ""; ""CONCLUSION ""; ""REFERENCES "" 327 $a""EPIDEMIC SEASONAL ATAXIC SYNDROME: EPIDEMIOLOGY, CLINICAL PRESENTATION, ETIOLOGICAL MECHANISMS AND THERAPY """"ABSTRACT ""; ""INTRODUCTION ""; ""ETIOLOGY ""; ""Viral Hypothesis ""; ""Toxins in Food""; ""Hypothesis of Thiamine Deficiency ""; ""CLINICAL PRESENTATION OF SAS IS COMPATIBLE WITH WERNICKEa???S ENCEPHALOPATHY ""; ""MECHANISM OF THIAMINE DEFICIENCY IN SEASONAL ATAXIC SYNDROME ""; ""THERAPY AND CONTROL OF SAS ""; ""REFERENCES ""; ""CLINICAL AND GENETIC ASPECTS OF RECESSIVE ATAXIAS ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""THE DEGENERATIVE ATAXIAS ""; ""Friedreicha???s Ataxia "" 327 $a""Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) "" 410 0$aNeuroscience Research Progress 606 $aAtaxia 606 $aMovement disorders 615 0$aAtaxia. 615 0$aMovement disorders. 701 $aHong$b Sung Hoi$01481248 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910779507103321 996 $aAtaxia$93698105 997 $aUNINA